BiOligo Biotechnology (Shanghai) Co., Ltd.
PrivateLast Round
Series A
Oct 22, 2021
Total Funding Raised
$46.95M
Company Overview
BiOligo Biotechnology (Shanghai) Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in October 2021.
BiOligo Biotechnology (Shanghai) Co., Ltd. is a life sciences company that specializes in the development and production of essential raw materials for in vitro diagnostics and nucleic acid drug applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiOligo Biotechnology (Shanghai) Co., Ltd. Comparables
Compare BiOligo Biotechnology (Shanghai) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou GenePharma Co., Ltd. | 78% | |
| BBI Life Sciences Corporation | 77% | |
| Thermo Fisher Scientific Inc. | 72% |
For institutional investors. Book with your work email.
BiOligo Biotechnology (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
BiOligo Biotechnology (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Carlyle Group | Series A |
| CICC Capital | Series A |
| BioVenture | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 78% MoM, reaching 1.3K.
- Oct 22, 2021
$47M round led by Carlyle Beijing Partners Fund II LP.
For institutional investors. Book with your work email.
BiOligo Biotechnology (Shanghai) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BiOligo Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.
Is BiOligo Biotechnology (Shanghai) Co., Ltd. a public or private company?
BiOligo Biotechnology (Shanghai) Co., Ltd. is a private company.
What is the current stock price of BiOligo Biotechnology (Shanghai) Co., Ltd.?
BiOligo Biotechnology (Shanghai) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks BiOligo Biotechnology (Shanghai) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BiOligo Biotechnology (Shanghai) Co., Ltd. worth (valuation)?
Valuation information for BiOligo Biotechnology (Shanghai) Co., Ltd. is not publicly available.
Can I buy BiOligo Biotechnology (Shanghai) Co., Ltd. stock?
BiOligo Biotechnology (Shanghai) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BiOligo Biotechnology (Shanghai) Co., Ltd.'s last funding round?
BiOligo Biotechnology (Shanghai) Co., Ltd.'s most recent funding round was Series A on October 22, 2021.
Who are the main investors in BiOligo Biotechnology (Shanghai) Co., Ltd.?
Key investors in BiOligo Biotechnology (Shanghai) Co., Ltd. include The Carlyle Group, CICC Capital, BioVenture.
Will BiOligo Biotechnology (Shanghai) Co., Ltd. IPO soon?
No public IPO plans have been announced for BiOligo Biotechnology (Shanghai) Co., Ltd..
How can I track BiOligo Biotechnology (Shanghai) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in BiOligo Biotechnology (Shanghai) Co., Ltd.'s shares on secondary markets.